← Back to all trials
Active Not Recruiting
NCT00496119
Proton Beam Therapy for Chordoma Patients
Conditions: Chordoma
Sex: All
Healthy volunteers: No
Phase: PHASE2
Enrollment: 19
Sponsor: M.D. Anderson Cancer Center
Location: University of Texas MD Anderson Cancer Center Houston Texas
Summary
The goal of this clinical research study is to learn if proton beam therapy, with or without photon beam radiation therapy, is effective in the treatment of skull base chordoma. The safety of this treatment will also be studied.
Eligibility Criteria
Inclusion Criteria:
1. Pathologically confirmed chordoma of the skull base
2. Contrast enhanced postoperative MRI (CT in case MRI is contraindicated) of the skull base obtained within 90 days of study registration
3. MDACC surgeons have determined that optimal debulking of disease has been performed.
4. Karnofsky Performance status greater than or equal to 60
5. Signed informed consent
Exclusion Criteria:
1. Previous irradiation of the skull base
2. Documented evidence of disseminated metastatic disease
3. Any concurrent malignancy (other than non-melanoma skin cancers) in the last 3 years
Source: ClinicalTrials.gov (NCT00496119). StuddyBuddy aggregates publicly available trial information.
